Fosun Pharma: Controlling subsidiary's drug approved for registration.

date
10/04/2026
Fosun Pharma announced that its holding subsidiary, Chongqing Yaoyou Pharmaceutical Co., Ltd., recently obtained approval from the National Medical Products Administration for the drug registration application of Ibuprofen Ester Injection. The approved indications for this time are for postoperative and cancer pain relief.